News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
109–144
Matches
2996
Sources here
16
Companies here
22
Search results Stored financial headlines

Active search

2996 matching headlines

Ticker or company: AXMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Bank Leumi partners with Galaxy for digital asset trading

Bank Leumi, Israel’s largest bank, has announced a partnership with Galaxy Digital Inc. to offer digital asset trading services to its customers, including Bitcoin, Ether, and Solana, through its Leumi Trade application. This initiative makes Bank Leumi the first Israeli bank to provide such …

GLXY main company
Sharemaestro market context Price below Trend Line 52 weeks -15.3% · Next-week setup negative 44.9% GLXY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Does MaxLinear (MXL) Have the Potential to Rally 31.25% as Wall Street Analysts Expect?

Wall Street analysts project MaxLinear (MXL) could rally 31.3%, with a mean price target of $100.6, despite a standard deviation of $15.68 indicating some variability in estimates. While analyst price targets alone can be misleading, MXL's strong agreement among analysts on upward earnings estimate …

MXL main company
Sharemaestro market context Trend signal active 52 weeks +418.9% MXL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Gaxos Plans Up to 6M $0.95 Warrants in Cash Deal

Gaxos (NASDAQ: GXAI) announced agreements for the immediate cash exercise of existing warrants for approximately $3.6 million in gross proceeds. These warrants cover up to 3,007,654 shares at a reduced exercise price of $1.20 per share. In return, Gaxos will issue new unregistered warrants …

GXAI main company
Sharemaestro market context Price below Trend Line 52 weeks -60.1% · Next-week setup negative 37.5% GXAI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Are Basic Materials Stocks Lagging Axalta Coating Systems (AXTA) This Year?

For those looking to find strong Basic Materials stocks, it is prudent to search for companies in the group that are outperforming their peers. Axalta Coating Systems (AXTA) is a stock that can certainly grab the attention of many investors, but do its recent …

AXTA main company
Sharemaestro market context Trend signal active 52 weeks +17.3% AXTA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Galaxy Digital director Douglas Deason buys $258k in stock

Douglas R. Deason, a director at Galaxy Digital Inc., purchased 12,000 shares of the company's Class A Common Stock for over $258,000. This insider purchase comes as the stock trades near its 52-week low, and InvestingPro analysis suggests it is undervalued. Despite a recent …

GLXY main company
Sharemaestro market context Price below Trend Line 52 weeks -15.3% · Next-week setup negative 44.9% GLXY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

RTW Investments discloses 9.99% Tenax Therapeutics (TENX) position with 2.87M shares

RTW Investments and Roderick Wong, M.D. have reported a beneficial ownership of 9.99% in Tenax Therapeutics, Inc., amounting to 2,866,654 shares. This stake includes shares issuable upon the exercise of warrants, subject to a 9.99% beneficial ownership limitation. The filing, a SCHEDULE 13G/A, details …

TENX main company
Sharemaestro market context Trend signal ended 52 weeks -70.0% TENX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Evaxion to announce business update and second quarter 2026 financial results on August 20, 2026

Evaxion COPENHAGEN, Denmark, August 14, 2026 - Evaxion A/S (NASDAQ: EVAX) ("Evaxion"), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will provide a business update and report its second quarter 2026 financial results on Thursday August 20, 2026, before opening …

EVAX main company
Sharemaestro market context Price below Trend Line 52 weeks +2.8% · Next-week setup negative 42.1% EVAX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insider Buys Additional US$100k In Galaxy Digital Stock

Independent Director Steven Bandrowczak recently purchased US$100k worth of Galaxy Digital (NASDAQ: GLXY) stock, although this was a small percentage increase in his holdings. Over the past year, insiders have sold more shares than they bought, with the largest sale being US$27m by President …

GLXY main company
Sharemaestro market context Price below Trend Line 52 weeks -15.3% · Next-week setup negative 44.9% GLXY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vaxcyte (NASDAQ:PCVX) Stock Rating Upgraded by Zacks Research

Zacks Research has upgraded Vaxcyte (NASDAQ:PCVX) from a "strong sell" to a "hold" rating, while the broader analyst consensus remains a "Moderate Buy" with an average price target of $86. The company recently reported a quarterly loss of $1.97 per share, outperforming estimates. Insider …

PCVX main company
Sharemaestro market context Price above Trend Line 52 weeks +79.8% PCVX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Galaxy Digital (NASDAQ:GLXY) Director Douglas Deason Acquires 12,000 Shares of Stock

Galaxy Digital Director Douglas Deason recently purchased 12,000 shares of the company's stock for $258,480, increasing his total holdings to 71,000 shares. The transaction, disclosed on August 12th, raises his position by over 20%. Despite a quarterly loss, Galaxy Digital surpassed analyst estimates, and …

GLXY main company
Sharemaestro market context Price below Trend Line 52 weeks -15.3% · Next-week setup negative 44.9% GLXY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Handelsbanken Fonder AB Has $10.38 Million Stock Position in Axsome Therapeutics, Inc. $AXSM

Handelsbanken Fonder AB significantly increased its stake in Axsome Therapeutics, Inc. by 216.4% in the second quarter, now holding 42,400 shares valued at $10.38 million. This comes despite Axsome Therapeutics missing analyst expectations for both earnings and revenue in its latest quarterly report. The …

AXSM main company
Sharemaestro market context Trend signal active 52 weeks +80.3% AXSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fairfax Financial Holdings (TSX:FFH) Stock Still Looks Below Fair Value On Earnings

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Fairfax Financial Holdings has delivered a very strong 338.3% return over the past 5 years, yet the stock has recently slipped, with the …

FFH main company
Sharemaestro market context Price below Trend Line 52 weeks -5.7% · Next-week setup positive 65.0% FFH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vision Retirement LLC Decreases Stock Position in Axon Enterprise, Inc $AXON

Vision Retirement LLC significantly reduced its stake in Axon Enterprise by 68.3%, selling 1,986 shares and retaining 920 shares valued at $516,000. Despite this, institutional ownership remains high at 79.08%, with major investors like Vanguard and Wellington increasing their positions. Axon reported strong quarterly …

AXON main company
Sharemaestro market context Trend signal active 52 weeks -20.0% AXON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SolarMax Technology, Inc. Financial Statements – FWB:6W10

This article provides an overview of SolarMax Technology, Inc.'s financial statements, emphasizing the absence of market capitalization, revenue, and net income data. It notes that the company has never paid dividends and currently has no plans to do so. SolarMax Technology is described as …

SMXT main company
Sharemaestro market context Price below Trend Line 52 weeks -71.9% · Next-week setup negative 42.5% SMXT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SolarMax Technology, Inc. Revenue Breakdown – FWB:6W10

This article provides a revenue breakdown for SolarMax Technology, Inc. (FWB:6W10), highlighting that the United States was the greatest contributor to its revenue in the last fiscal year, bringing in €77.46 million, an increase from €22.20 million the prior year. The data is presented …

SMXT main company
Sharemaestro market context Price below Trend Line 52 weeks -71.9% · Next-week setup negative 42.5% SMXT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SolarMax Technology, Inc. Income Statement – FWB:6W10

This article presents the income statement for SolarMax Technology, Inc. (FWB:6W10), detailing financial statements including revenue, expenses, and profit. The total revenue for the last quarter was €12.84 million, a 67.63% decrease from the previous quarter, with a net income of -€265.44 thousand for …

SMXT main company
Sharemaestro market context Price below Trend Line 52 weeks -71.9% · Next-week setup negative 42.5% SMXT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Gaxos Announces Exercise of Warrants for Approximately $3.6 Million Gross Proceeds

Gaxos.ai Inc. (NASDAQ: GXAI) announced definitive agreements for the immediate exercise of outstanding warrants, generating approximately $3.6 million in gross proceeds. The warrants, originally issued in December and September 2024 with exercise prices between $2.33 and $3.32 per share, are being exercised at a …

GXAI main company
Sharemaestro market context Price below Trend Line 52 weeks -60.1% · Next-week setup negative 37.5% GXAI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GSK plc (GSK) 13F filing lists 13 U.S. positions worth over $602M

GSK plc has filed a Form 13F Holdings Report, disclosing 13 U.S. securities positions with a total aggregate value of $602,220,442. This filing indicates that GSK plc is the sole institutional investment manager responsible for these holdings, with no other managers included in the …

GSK main company
Sharemaestro market context Price below Trend Line 52 weeks +26.3% · Next-week setup positive 55.6% GSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teleconferência de Resultados do 2T26 da MaxCyte (MXCT): Guidance Reafirmado com a Expansão da Parceria com a Genentech

MaxCyte reported Q2 2026 total revenue of $7.3 million, a 15% year-over-year decrease but exceeding expectations due to sequential growth in instrument allocations and processing assembly demand. The company reaffirmed its full-year revenue guidance of $30 million to $32 million, anticipating low single-digit growth …

MXCT main company
Sharemaestro market context Trend signal active 52 weeks -7.0% · Next-week setup negative 39.3% MXCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Axon Enterprise, Inc $AXON Shares Bought by EverSource Wealth Advisors LLC

EverSource Wealth Advisors LLC significantly increased its stake in Axon Enterprise (NASDAQ:AXON) during the second quarter, now holding 3,666 shares valued at $2.06 million. This comes as Axon reported strong Q2 earnings, exceeding expectations with adjusted EPS of $1.88 and revenue of $904.4 million, …

AXON main company
Sharemaestro market context Trend signal active 52 weeks -20.0% AXON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Conferencia de resultados del T2 de 2026 de MaxCyte (MXCT): Se reafirman las proyecciones a medida que se amplía la alianza con Genentech

MaxCyte (MXCT) reportó ingresos totales de $7.3 millones en el segundo trimestre de 2026, una disminución del 15% interanual, pero reafirmó sus proyecciones anuales de ingresos entre $30 y $32 millones. La empresa destacó una nueva alianza multiplataforma con Genentech, que abarca múltiples programas …

MXCT main company
Sharemaestro market context Trend signal active 52 weeks -7.0% · Next-week setup negative 39.3% MXCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ABN Amro Investment Solutions Sells 1,956 Shares of Axon Enterprise, Inc $AXON

ABN Amro Investment Solutions recently reduced its stake in Axon Enterprise, Inc. by selling 1,956 shares, retaining 5,849 shares valued at $3.28 million. This comes as Axon reported strong Q2 earnings, beating analyst expectations with revenue up 35.3% year-over-year. Despite a "Moderate Buy" consensus …

AXON main company
Sharemaestro market context Trend signal active 52 weeks -20.0% AXON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context